Two more biotechs, Marea and North Immunology, do reverse mergers

Neutral

AI Analysis

Summary

Marea and North Immunology announced reverse merger transactions. Marea is a cardio and endocrine startup with two drugs in Phase 2, while North Immunology is developing long-acting immunology and inflammation therapies.

Outcome Details

reverse merger

Importance:4/10

Sentiment:

0.00

reverse mergerM&AcardiologyendocrinologyimmunologyinflammationPhase 2

Related Companies

$CDIOW $DMIIR

Read the original article

Published by Endpoints News on September 17, 2026 3:35 PM

Read Original